Icon Wealth Partners, LLC Immuno Gen, Inc. Transaction History

Icon Wealth Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$1.8 - $3.3 $8,706 - $15,962	-4,837 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$2.41 - $5.91 $11,657 - $28,586	4,837 New	4,837 $13,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $24,200 - $31,685	-2,814 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$9.52 - $12.15 $26,789 - $34,190	2,814 New	2,814 $27,000
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $24,910 - $48,148	-3,718 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$5.07 - $7.92 $18,850 - $29,446	3,718	3,718 $24,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Icon Wealth Partners, LLC with notifications on news.